RCEL Stock Analysis: Buy, Sell, or Hold?
RCEL - Avita Medical, Inc. Common Stock
$4.23
0.26 (6.55%)
▲
5d:
+4.96%
30d:
-3.64%
90d:
+10.73%
BUY
HIGH Confidence
Analysis Updated: Jun 29, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When RCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RCEL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: RCEL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: RCEL is currently trading at $4.23, which is considered fair relative to its 30-day fair value range of $3.95 to $4.33. From a valuation perspective, the stock is trading at a discount (Forward PE: -3.5) compared to its historical average (8.0). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, RCEL is showing sideways momentum. Immediate support is located at $3.95, while resistance sits at $4.55. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: RCEL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $7.00 (+76.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RCEL is showing sideways momentum. Immediate support is located at $3.95, while resistance sits at $4.55. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: RCEL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $7.00 (+76.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.95 -
$4.33
Company Quality Score
53/100
(HOLD)
Options IV Signal
21th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
94.2%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 21th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.5%)
- BULLISH: Trading 76.2% below Wall St target ($7.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$3.95 -
$4.33
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.88
(20.8%)
Support & Resistance Levels
Support Level
$3.95
Resistance Level
$4.55
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.47
Wall Street Target
$7.00
(+76.2%)
Revenue Growth (YoY)
4.0%
Profit Margin
-62.7%
PE vs Historical
-3.5 vs 8.0
CHEAP
Share & Embed Analysis
Last updated: June 29, 2026 2:36 PM ET
Data refreshes hourly during market hours. Next update: 3:36 PM
Data refreshes hourly during market hours. Next update: 3:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCEL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
David D O'toole
BUY
3000 shares
2026-02-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 60 BUY |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 67 BUY |
